{
    "SPADE_N_13497": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13497",
            "Peptide Name": "Magainin-AM2 (UCLL1a; natural AMPs; frog, amphibians, animals)",
            "Source": "the octoploid frogXenopus amieti(Pipidae)",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GVSKILHSAGKFGKAFLGEINKS",
            "Sequence Length": 23,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-",
                "anti-diabetes"
            ],
            "Target Organism": "Active against E. coli (MIC 50 uM).",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2388.76,
            "PI": 10.0,
            "Hydrophobicity": 0.01,
            "Half Life": "Not found",
            "Literature": [
                {
                    "Author": "Conlon JM, Al-Ghaferi N, Ahmed E, Meetani MA, Leprince J, Nielsen PF.2010",
                    "Reference": "Peptides. 2010 Jun;31(6):989-94.PubMed",
                    "Title": "Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae)."
                }
            ],
            "Frequent Amino Acids": "GKS",
            "Absent Amino Acids": "CDMOPQRTUWY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 9,
            "Polar Residues": 12,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Net Charge": 4,
            "Function": "This peptide promotes the release of the incretin peptide, glucagon-like peptide-1 from the GLUTagmurine enteroendocrine cell line (Ojo et al.Biochem Biophy Res Commun 431:14-18), thereby having the potentil to be developed as a drug for type 2 diabetes (T2D).  Magainin-AM1, not antimicrobial, can bind to LPS (McLean et al., 2014).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_03582",
                    "Similarity": 0.9565217391304348,
                    "Sequence": "GVSKILHSAGKFGKAFLGEIMKS"
                },
                {
                    "SPADE_ID": "SPADE_UN_13158",
                    "Similarity": 0.8,
                    "Sequence": "GIGKFLHSAKFGKAFVEINK"
                },
                {
                    "SPADE_ID": "SPADE_UN_13232",
                    "Similarity": 0.8,
                    "Sequence": "GIGKFLHSAKFGKAFGEINS"
                }
            ]
        }
    }
}